Finished Dose

Our finished dose offering comprises a range of capabilities in manufacturing and packaging, meeting the diverse needs of customers from the pre-clinical stage to high volume commercial supply.

Technologies

Our finished dose capabilities include:

  • Tech transfer expertise and experience
  • Bulk commercial manufacture of human and veterinary products
    • Solids; Wet/dry granulation, tablet production, encapsulation, granules, pellets, iron and nitrate products
    • Liquids; oral, volatile and parenteral
    • Terminal sterilisation; ampoules and vials
  • Packaging and labelling for a broad range of dosage forms
  • Component and device assembly
  • Important and release services for market supply
  • Ability to handle potent and controlled drugs
    • Potent drugs up to Safebridge Category 3
    • Controlled drug handling to Schedule 2

Our wider packaging capabilities include:

  • Primary packaging
  • Secondary packaging
  • Packaging design
  • Artwork services
  • Serialisation

THE WHOLE SUPPLY CHAIN. SIMPLIFIED.

How Aesica can add value at every stage

API development API manufacture Finished dose development